leah_ferrers
Fourth batch tested independently. Two surprises so far.
12kreputation
23answers
2accepted
23questions
0·1·6badges g·s·b
58tags
142Is a 30G needle the right choice for drawing a GLP-1 receptor agonist at 6.67 mg/mL?accepted · answered 5 Aug 2025 · needle-gauge, injection-technique, dead-space96Does the STEP 1 population resemble anyone asking about semaglutide here?answered 5 Nov 2024 · clinical-trials, harm-reduction, semaglutide80Can I reconstitute survodutide at 2 mg/mL and still measure a small dose accurately?answered 29 Jun 2024 · diluent-volume, insulin-syringe, dosing-math40Is an 18G drawing needle the right choice for drawing orforglipron at 2 mg/mL?answered 21 Jun 2026 · needle-gauge, injection-technique, dead-space35What is the dead-space loss per draw with a 27G needle at 3.33 mg/mL?answered 30 Mar 2025 · dead-space, insulin-syringe, dosing-math34Would you accept 97.9% on ecnoglutide from SWB without a content assay?answered 6 Jan 2026 · purity, content-assay, vendor-vetting33What does a batch certificate on a WXT report change about how I read it?answered 6 Jul 2024 · coa, batch-testing, vendor-vetting32Does a free androgen index respond faster than the symptoms do?answered 11 Jan 2025 · pcos, hormones, bloodwork31What did the placebo arm of STEP 8 report for dizziness?answered 22 Aug 2025 · clinical-trials, harm-reduction30If I reconstitute a 2 mg vial with 1.5 mL of sterile water for injection, what concentration do I end up with?answered 1 Aug 2025 · reconstitution, diluent-volume, dosing-math26Is a sampling plan from WXT sufficient basis to skip independent testing?answered 15 Sept 2025 · coa, batch-testing, harm-reduction25What is the arithmetic to convert 4 mg in 2 mL into units on a U-100 scale?answered 20 Dec 2025 · dosing-math, insulin-syringe, reconstitution24What is the dead-space loss per draw with a 30G needle at 5 mg/mL?answered 1 Jan 2025 · dead-space, insulin-syringe, dosing-math13How does WXT compare to GL Biochem (Shanghai) on documentation quality?answered 18 Jun 2024 · vendor-comparison, coa, vendor-vetting10What does ATTAIN-1 tell me about dizziness at the 24 mg dose?answered 15 Apr 2026 · clinical-trials, titration9Is a 31G needle the right choice for drawing survodutide at 5 mg/mL?answered 14 Jul 2026 · needle-gauge, injection-technique, dead-space9Is an 18G drawing needle the right choice for drawing retatrutide at 5 mg/mL?answered 25 Jul 2026 · needle-gauge, injection-technique, dead-space9Why is comparing a 10 mg vial to a 4-dose pen apples-to-oranges, and how much does dead space really cost?answered 1 Mar 2025 · cost-analysis, dead-space, insulin-syringe8How many times can I pierce a stopper with a 31G needle before coring?accepted · answered 22 Dec 2025 · needle-gauge, sterility, vial-inspection7Does early satiety at week two of orforglipron usually resolve without a dose change?answered 6 Feb 2026 · gi-side-effects, titration, orforglipron6What is the dead-space loss per draw with a 25G drawing needle at 3.33 mg/mL?answered 10 Oct 2024 · dead-space, insulin-syringe, dosing-math1What is the dead-space loss per draw with a 27G needle at 5 mg/mL?answered 6 May 2024 · dead-space, insulin-syringe, dosing-math-2Is ferritin worth drawing at baseline before starting liraglutide?answered 11 Nov 2025 · bloodwork, harm-reduction, a1c